Adult T-cell leukemia: a review of epidemiological evidence

Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as southwestern Japan, the Caribbean islands, Central and South America, Intertropical Africa, and Middle East. To date, many...

Full description

Bibliographic Details
Main Authors: Masako eIwanaga, Toshiki eWatanabe, Kazunari eYamaguchi
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-09-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00322/full
_version_ 1828159769476595712
author Masako eIwanaga
Toshiki eWatanabe
Kazunari eYamaguchi
author_facet Masako eIwanaga
Toshiki eWatanabe
Kazunari eYamaguchi
author_sort Masako eIwanaga
collection DOAJ
description Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as southwestern Japan, the Caribbean islands, Central and South America, Intertropical Africa, and Middle East. To date, many epidemiological studies have been conducted to investigate the incidence of ATL among general population or HTLV-1 carriers and to identify a variety of laboratory, molecular, and host-specific markers to be possible predictive factors for developing ATL because HTLV-1 infection alone is not sufficient to develop ATL. This literature review focuses on the epidemiology of ATL and the risk factors for the development of ATL from HTLV-1 carriers, while keeping information on the epidemiology of HTLV-1 to a minimum. The main lines of epidemiological evidence are: (1) ATL occurs mostly in adults, at least 20–30 years after the HTLV-1 infection, (2) age at onset differs across geographic areas: the average age in the Central and South America (around 40 years old) is younger than that in Japan (around 60 years old), (3) ATL occurs in those infected in childhood, but seldom occurs in those infected in adulthood, (4) male carriers have about a 3–5 fold higher risk of developing ATL than female, (5) the estimated life-time risk of developing ATL in HTLV-1 carriers is 6–7% for men and 2–3% for women in Japan, (6) a low anti-Tax reactivity, a high soluble interleukin-2 receptor level, a high anti-HTLV-1 titer, and high levels of circulating abnormal lymphocytes and white blood cell count are accepted risk factors for the development of ATL, and (7) a higher proviral load (more than 4 copies/100 peripheral blood mononuclear cells) is an independent risk factor for progression of ATL. Nevertheless, the current epidemiological evidence is insufficient to fully understand the relationship between HTLV-1 infection and ATL. Further well-designed epidemiological studies are needed.
first_indexed 2024-04-12T00:06:18Z
format Article
id doaj.art-8471db30b75c4635a02fcc1a99a9dda9
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-12T00:06:18Z
publishDate 2012-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-8471db30b75c4635a02fcc1a99a9dda92022-12-22T03:56:05ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2012-09-01310.3389/fmicb.2012.0032229018Adult T-cell leukemia: a review of epidemiological evidenceMasako eIwanaga0Toshiki eWatanabe1Kazunari eYamaguchi2 Graduate School of Public Health, Teikyo UniversityGraduate School of Frontier Sciences, The University of TokyoDepartment of Safety Research on Blood and Biologics, National Institute of Infectious DiseasesAdult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as southwestern Japan, the Caribbean islands, Central and South America, Intertropical Africa, and Middle East. To date, many epidemiological studies have been conducted to investigate the incidence of ATL among general population or HTLV-1 carriers and to identify a variety of laboratory, molecular, and host-specific markers to be possible predictive factors for developing ATL because HTLV-1 infection alone is not sufficient to develop ATL. This literature review focuses on the epidemiology of ATL and the risk factors for the development of ATL from HTLV-1 carriers, while keeping information on the epidemiology of HTLV-1 to a minimum. The main lines of epidemiological evidence are: (1) ATL occurs mostly in adults, at least 20–30 years after the HTLV-1 infection, (2) age at onset differs across geographic areas: the average age in the Central and South America (around 40 years old) is younger than that in Japan (around 60 years old), (3) ATL occurs in those infected in childhood, but seldom occurs in those infected in adulthood, (4) male carriers have about a 3–5 fold higher risk of developing ATL than female, (5) the estimated life-time risk of developing ATL in HTLV-1 carriers is 6–7% for men and 2–3% for women in Japan, (6) a low anti-Tax reactivity, a high soluble interleukin-2 receptor level, a high anti-HTLV-1 titer, and high levels of circulating abnormal lymphocytes and white blood cell count are accepted risk factors for the development of ATL, and (7) a higher proviral load (more than 4 copies/100 peripheral blood mononuclear cells) is an independent risk factor for progression of ATL. Nevertheless, the current epidemiological evidence is insufficient to fully understand the relationship between HTLV-1 infection and ATL. Further well-designed epidemiological studies are needed.http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00322/fullEpidemiologyHTLV-1ATLAdult T-cell leukemiahuman T-cell leukemia virus type I
spellingShingle Masako eIwanaga
Toshiki eWatanabe
Kazunari eYamaguchi
Adult T-cell leukemia: a review of epidemiological evidence
Frontiers in Microbiology
Epidemiology
HTLV-1
ATL
Adult T-cell leukemia
human T-cell leukemia virus type I
title Adult T-cell leukemia: a review of epidemiological evidence
title_full Adult T-cell leukemia: a review of epidemiological evidence
title_fullStr Adult T-cell leukemia: a review of epidemiological evidence
title_full_unstemmed Adult T-cell leukemia: a review of epidemiological evidence
title_short Adult T-cell leukemia: a review of epidemiological evidence
title_sort adult t cell leukemia a review of epidemiological evidence
topic Epidemiology
HTLV-1
ATL
Adult T-cell leukemia
human T-cell leukemia virus type I
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00322/full
work_keys_str_mv AT masakoeiwanaga adulttcellleukemiaareviewofepidemiologicalevidence
AT toshikiewatanabe adulttcellleukemiaareviewofepidemiologicalevidence
AT kazunarieyamaguchi adulttcellleukemiaareviewofepidemiologicalevidence